Levetiracetam Tablet, Film Coated, Extended Release
Product Images NDC 70518-4125

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-4125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a medication description for LevETIRAcetam Extended-Release 500 mg Tablet. It comes in a quantity of 30 tablets and is available by prescription only. The manufacturer is Westminster Pharma located in Olive Branch, MS. The medication should be stored at a temperature of 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). For directions on usage, refer to the package insert. Keep this medication out of reach of children.*

FDA Label Image

Chemical Structure (Levetiracetam 01)

FDA Label Image

Figure 1 (Levetiracetam 02)

FDA Label Image

Figure 2 (Levetiracetam 03)

The provided text includes various percentage values and the phrase "statistically significant versus placebo." Based on this information, it seems to pertain to statistical significance testing in comparison to a placebo group, possibly in a research or study context. The percentages indicated could represent different results or outcomes within the study, although the exact details or context are not clearly discernible from the text.*

FDA Label Image

Figure 3 (Levetiracetam 04)

This text appears to be a statistical summary comparing the effectiveness of a placebo and immediate-release levetiracetam in the treatment of patients. The table shows various percentages of patients across different groups, with some values being statistically significant. Unfortunately, the output is not readable in some places, leading to incomplete information.*

FDA Label Image

Figure 4 (Levetiracetam 05)

This text includes data regarding the percentage of patients in a study comparing a placebo group (N=97) with an immediate-release levetiracetam group (N=101). The percentages range from 0% to 45%. It mentions statistical significance against the placebo group.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.